In patients with PAH, a significant increase in plasma Ang II levels has been reported, accompanied by a decrease in Ang-(1–7) and Ang-(1–9) and a decrease in ACE2 activity [9,10]. This evidence concerns the gene AGT and pulmonary arterial hypertension.